Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rod Kunynetz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Dermatology : EJD|January 14, 2011
Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled studyRod Kunynetz, Wayne Carey, Richard Thomas, et al.
Journal of Cutaneous Medicine and Surgery|September 28, 2017
Acitretin Use in DermatologyLyn C Guenther, Rod Kunynetz, Charles W Lynde, et al.
Lancet (London, England)|February 17, 2009
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trialAlice Gottlieb, Alan Menter, Alan Mendelsohn, et al.
Journal of Drugs in Dermatology : JDD|October 3, 2013
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab useCarrie Brodmerkel, Eric Wadman, Richard G Langley, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Dermatology : EJD|January 14, 2011
Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled studyRod Kunynetz, Wayne Carey, Richard Thomas, et al.
Journal of Cutaneous Medicine and Surgery|September 28, 2017
Acitretin Use in DermatologyLyn C Guenther, Rod Kunynetz, Charles W Lynde, et al.
Lancet (London, England)|February 17, 2009
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trialAlice Gottlieb, Alan Menter, Alan Mendelsohn, et al.
Journal of Drugs in Dermatology : JDD|October 3, 2013
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab useCarrie Brodmerkel, Eric Wadman, Richard G Langley, et al.
Pageof 1